The thrombocytopenic purpura in pregnancy is an autoimmune disease in which the own the body’s antibodies destroy the platelets of the blood. This disease can be serious, especially if not well monitored and treated, because the mother’s antibodies can pass to the fetus.
The treatment of this disease can be done with corticoids and gamaglobulinas and, in more severe cases, it may be necessary to perform a platelet transfusion or even removal of the spleen.
What are the risks
Women suffering from thrombocytopenic purpura in pregnancy may be at risk during childbirth. In some cases it may occur bleeding of the baby during labour, may cause therefore injury or even death of the baby because the mother’s antibodies to be passed on to the baby, can lead to a decrease in the number of platelets of the baby during the pregnancy or immediately after birth.
How is the diagnosis made
By conducting an examination of the blood of the umbilical cord during gestation, it is possible to determine the presence or not of antibodies, and detecting the number of platelets in the fetus, in order to prevent these complications.
If the antibodies are come to the fetus, can be performed a caesarean section, by appointment of an obstetrician, to avoid problems during birth, such as cerebral hemorrhage in the newborn, for example.
What is the treatment
The treatment for purpura in pregnancy can be done with corticoids and gamaglobulinas, to improve the clotting blood of a pregnant woman temporarily, preventing bleeding and allowing the labor to be induced with safety, without the occurrence of an uncontrollable bleeding.
In situations of greater gravity, can be made a transfusion of platelets and until the withdrawal of the spleen, to avoid the destruction of more platelets.